157 related articles for article (PubMed ID: 33719151)
1. Prodrug Activation by Gold Artificial Metalloenzyme-Catalyzed Synthesis of Phenanthridinium Derivatives via Hydroamination.
Chang TC; Vong K; Yamamoto T; Tanaka K
Angew Chem Int Ed Engl; 2021 May; 60(22):12446-12454. PubMed ID: 33719151
[TBL] [Abstract][Full Text] [Related]
2. In-Cell Generation of Anticancer Phenanthridine Through Bioorthogonal Cyclization in Antitumor Prodrug Development.
Maslah H; Skarbek C; Gourson C; Plamont MA; Pethe S; Jullien L; Le Saux T; Labruère R
Angew Chem Int Ed Engl; 2021 Nov; 60(45):24043-24047. PubMed ID: 34487611
[TBL] [Abstract][Full Text] [Related]
3. Transition Metal-mediated Uncaging Chemistry in Prodrug Design.
Shu HY; De Zhu R; Wu J; Liu XH; Shi JB
Curr Top Med Chem; 2021; 21(24):2205-2212. PubMed ID: 34170808
[TBL] [Abstract][Full Text] [Related]
4. Bioorthogonal strategies for the in vivo synthesis or release of drugs.
Lozhkin B; Ward TR
Bioorg Med Chem; 2021 Sep; 45():116310. PubMed ID: 34365101
[TBL] [Abstract][Full Text] [Related]
5. Bioorthogonal release of anticancer drugs
Vong K; Yamamoto T; Chang TC; Tanaka K
Chem Sci; 2020 Sep; 11(40):10928-10933. PubMed ID: 34094342
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
Wang Y; Jiang J; Jiang X; Cai S; Han H; Li L; Tian Z; Jiang W; Zhang Z; Xiao Y; Wright SC; Larrick JW
Bioorg Med Chem; 2008 Jul; 16(13):6552-9. PubMed ID: 18508273
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-triggered prodrugs: Design strategies, potential applications, and perspectives.
Zhao J; Li X; Ma T; Chang B; Zhang B; Fang J
Med Res Rev; 2024 May; 44(3):1013-1054. PubMed ID: 38140851
[TBL] [Abstract][Full Text] [Related]
9. Designing Prodrugs Based on Special Residues of Human Serum Albumin.
Gou Y; Yang F; Liang H
Curr Top Med Chem; 2016; 16(9):996-1008. PubMed ID: 26303424
[TBL] [Abstract][Full Text] [Related]
10. Anticancer Approach Inspired by the Hepatotoxic Mechanism of Pyrrolizidine Alkaloids with Glycosylated Artificial Metalloenzymes.
Kurimoto M; Chang TC; Nishiyama Y; Suzuki T; Dohmae N; Tanaka K; Yokoshima S
Angew Chem Int Ed Engl; 2022 Oct; 61(43):e202205541. PubMed ID: 36062554
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Multiple-Substituted Pyrroles via Gold(I)-Catalyzed Hydroamination/Cyclization Cascade.
Li X; Chen M; Xie X; Sun N; Li S; Liu Y
Org Lett; 2015 Jun; 17(12):2984-7. PubMed ID: 26030605
[TBL] [Abstract][Full Text] [Related]
12. HSA IIA subdomain-based developing anticancer metal prodrug: a new and improved approach.
Yang F; Liang H
Future Med Chem; 2016; 8(2):89-91. PubMed ID: 26824398
[No Abstract] [Full Text] [Related]
13. Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives.
Akinboye ES; Rosen MD; Bakare O; Denmeade SR
Bioorg Med Chem; 2017 Dec; 25(24):6707-6717. PubMed ID: 29153549
[TBL] [Abstract][Full Text] [Related]
14. Gold-catalyzed hydroamination/cycloisomerization reaction of 1,6-enynes.
Leseurre L; Toullec PY; Genêt JP; Michelet V
Org Lett; 2007 Sep; 9(20):4049-52. PubMed ID: 17824708
[TBL] [Abstract][Full Text] [Related]
15. A minimally-masked inactive prodrug of panobinostat that is bioorthogonally activated by gold chemistry.
Rubio-Ruiz B; Pérez-López AM; Sebastián V; Unciti-Broceta A
Bioorg Med Chem; 2021 Jul; 41():116217. PubMed ID: 34022529
[TBL] [Abstract][Full Text] [Related]
16. Prodrugs for nitroreductase-based cancer therapy-3: Antitumor activity of the novel dinitroaniline prodrugs/Ssap-NtrB enzyme suicide gene system: Synthesis, in vitro and in silico evaluation in prostate cancer.
Tokay E; Güngör T; Hacıoğlu N; Önder FC; Gülhan ÜG; Tok TT; Çelik A; Ay M; Köçkar F
Eur J Med Chem; 2020 Feb; 187():111937. PubMed ID: 31841727
[TBL] [Abstract][Full Text] [Related]
17. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a photoresponsive doxorubicin/combretastatin A4 hybrid prodrug.
Liu W; Liang L; Zhao L; Tan H; Wu J; Qin Q; Gou X; Sun X
Bioorg Med Chem Lett; 2019 Feb; 29(3):487-490. PubMed ID: 30553736
[TBL] [Abstract][Full Text] [Related]
19. Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells.
Kelly GJ; Kia AF; Hassan F; O'Grady S; Morgan MP; Creaven BS; McClean S; Harmey JH; Devocelle M
Org Biomol Chem; 2016 Oct; 14(39):9278-9286. PubMed ID: 27722734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
